ML-192
ML-192
ML-192 is a chemical compound that has garnered interest in the field of medical research due to its potential therapeutic applications. This article provides a comprehensive overview of ML-192, including its chemical properties, mechanism of action, and potential uses in medicine.
Chemical Properties[edit]
ML-192 is a small molecule inhibitor with the chemical formula C₁₉H₁₈N₂O₃. It is characterized by its aromatic structure and the presence of functional groups that contribute to its biological activity. The compound is synthesized through a series of organic reactions, which involve the formation of key intermediates that are subsequently modified to yield the final product.
Mechanism of Action[edit]
ML-192 functions primarily as an inhibitor of the enzyme PARP1 (Poly (ADP-ribose) polymerase 1). PARP1 is involved in the repair of single-strand DNA breaks through the base excision repair pathway. By inhibiting PARP1, ML-192 prevents the repair of DNA damage, leading to the accumulation of DNA breaks and ultimately cell death. This mechanism is particularly effective in cancer cells that rely heavily on PARP1 for survival.
Therapeutic Applications[edit]
ML-192 has shown promise in preclinical studies as a potential treatment for various types of cancer, including breast cancer, ovarian cancer, and prostate cancer. Its ability to selectively target cancer cells while sparing normal cells makes it an attractive candidate for further development. Additionally, ML-192 is being investigated for its role in enhancing the efficacy of existing chemotherapeutic agents by sensitizing cancer cells to DNA-damaging treatments.
Research and Development[edit]
Ongoing research is focused on optimizing the pharmacokinetic properties of ML-192 to improve its bioavailability and reduce potential side effects. Clinical trials are being designed to evaluate the safety and efficacy of ML-192 in human subjects, with the aim of advancing it through the drug development pipeline.
Also see[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

